Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-339193
Filing Date
2011-12-13
Accepted
2011-12-13 13:38:09
Documents
14
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d259667d10k.htm 10-K 1171914
2 FORM OF CHANGE OF CONTROL AGREEMENT d259667dex1024.htm EX-10.24 51461
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d259667dex231.htm EX-23.1 1703
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d259667dex311.htm EX-31.1 9642
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER d259667dex312.htm EX-31.2 10329
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER d259667dex321.htm EX-32.1 3392
7 CERTIFICATION OF CHIEF FINANCIAL OFFICER d259667dex322.htm EX-32.2 2905
14 GRAPHIC g259667g01v51.jpg GRAPHIC 70352
  Complete submission text file 0001193125-11-339193.txt   4031618

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT avnr-20110930.xml EX-101.INS 571091
9 XBRL TAXONOMY EXTENSION SCHEMA avnr-20110930.xsd EX-101.SCH 16751
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avnr-20110930_cal.xml EX-101.CAL 38112
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avnr-20110930_def.xml EX-101.DEF 13212
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE avnr-20110930_lab.xml EX-101.LAB 153195
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avnr-20110930_pre.xml EX-101.PRE 91430
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-15803 | Film No.: 111258085
SIC: 2834 Pharmaceutical Preparations